Zurich, Switzerland

Bernhard Steffen Thomaszewski

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Align Technology, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Bernhard Steffen Thomaszewski

Introduction

Bernhard Steffen Thomaszewski is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of orthognathic treatment through his innovative patent. His work focuses on improving patient outcomes by utilizing advanced treatment parameter estimation techniques.

Latest Patents

Thomaszewski holds a patent titled "Treatment parameter estimation using orthognathic information." This method involves receiving orthognathic patient data that represents the initial state of a patient, along with a plurality of treatment parameters based on the treatment goal. The process generates an output state of the patient, calculates an objective function based on this output, and updates the treatment parameters accordingly. He has 1 patent to his name.

Career Highlights

Bernhard Steffen Thomaszewski is currently employed at Align Technology, Inc., a company known for its innovative solutions in dental and orthodontic care. His work at Align Technology has allowed him to apply his expertise in orthognathic treatment, contributing to advancements in patient care.

Collaborations

Throughout his career, Thomaszewski has collaborated with talented professionals, including Janik Lobsiger and Daniel Michel Peter. These collaborations have fostered a creative environment that encourages innovation and the development of new ideas in the field.

Conclusion

Bernhard Steffen Thomaszewski is a distinguished inventor whose work in orthognathic treatment has the potential to significantly enhance patient care. His innovative approach and dedication to improving treatment outcomes are commendable.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…